Efforts to address shortcomings in racial and ethnic diversity in clinical trials are often siloed and not well publicized, limiting their reach and potential for transformation. This session will touch on why a coordinated approach is necessary to effect wide-spread change and outline what three leading organizations are doing.
Speaker
Director, Forum on Drug Discovery, Development, and Translation
National Academies of Sciences, Engineering, and Medicine